Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $36,250 - $50,340
-500 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$90.24 - $124.05 $45,120 - $62,025
500 New
500 $48,000
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $836 - $1,391
-15 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $388 - $498
-5 Reduced 25.0%
15 $1,000
Q3 2018

Nov 13, 2018

SELL
$48.29 - $80.6 $386 - $644
-8 Reduced 28.57%
20 $2,000
Q2 2018

Aug 13, 2018

SELL
$37.84 - $69.96 $1,021 - $1,888
-27 Reduced 49.09%
28 $2,000
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $2,190 - $3,164
55 New
55 $2,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.07B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.